Osuga Y

No ORCID on file · 210 papers in corpus · active 1999-2026

Study types

  • article 121
  • other 29
  • review 12
  • preprint 8
  • case-report 4

Condition tags

  • endometriosis 153
  • adenomyosis 37
  • endometrioma 34
  • dysmenorrhea 21
  • infertility 19
  • chronic_pelvic_pain 10
  • dyspareunia 5
  • bowel_endometriosis 4
  • bladder_endometriosis 3
  • mesh:D004716 3
other 2026
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-025-02045-9

The association between adenomyosis and uterine torsion, a rare, serious obstetric condition, remains unclear and has not been systematically investigated. This study aimed to elucidate the incidence, risk factors, and clinical characterist…

preprint 2026
·doi:10.21203/rs.3.rs-8631039/v1

Abstract Background: The implantation (retrograde menstruation) theory hypothesizes that endometriosis arises when refluxed endometrial cells implant at ectopic sites; however, a fallopian tube epithelial origin has also been proposed. …

other 2026
Reproductive medicine and biology ·doi:10.1002/rmb2.70021

PURPOSE: To clarify the efficacy and safety of the estetrol 15 mg/drospirenone 3 mg combination among Japanese women with adenomyosis by post hoc analyses of a previous randomized clinical study. METHODS: Post hoc analyses were performed u…

2026
Scientific reports ·doi:10.1038/s41598-026-48676-z

Ovarian clear cell carcinoma (OCCC) is a chemoresistant subtype of epithelial ovarian cancer with limited therapeutic options and distinct molecular features. Histone methyltransferase SETD8 catalyzes the monomethylation of histone H4 at ly…

2026
BMC women's health ·doi:10.1186/s12905-026-04308-2

BACKGROUND: The impact of body mass index (BMI) on reproductive health is well-established, but the effect of within-individual changes in BMI on the menstrual cycle, a valuable and accessible indicator of reproductive health, remains less …

2025
Women's health (London, England) ·doi:10.1177/17455057251347088

BackgroundWomen's health is significantly influenced by the appropriate and timely secretion of female sex steroid hormones. Consequently, awareness of hormonal fluctuations at various life stages is crucial. In 2016, the Japanese Ministry …

2025
Journal of ovarian research ·doi:10.1186/s13048-025-01732-0

BackgroundThe age-related decline of fertility is caused by a reduction of the ovarian reserve, which is represented by the number and quality of oocytes in the ovaries. Anti-Müllerian hormone (AMH) is considered one of the most useful mark…

article 2025
BMC pregnancy and childbirth ·doi:10.1186/s12884-025-08454-7

BACKGROUND: With the increasing incidence of autism spectrum disorder (ASD), various risk factors for ASD have been identified. Among them, maternal immune activation (MIA), which can be triggered by inflammation via elevated proinflammator…

2025
Oncology letters ·doi:10.3892/ol.2024.14852

Although ovarian endometrioid carcinoma (OEC), frequently associated with endometrial endometrioid carcinoma (EEC), is often diagnosed at an early stage, the prognosis remains poor. The development of new, effective drugs to target these ca…

2025
Scientific reports ·doi:10.1038/s41598-025-92906-9

Chronic endometritis (CE) and endometrial dysbiosis (ED) are major causes of recurrent implantation failure (RIF). CE is diagnosed via hysteroscopy or the endometrial CD138 test; ED is examined using endometrial microbiome testing with next…

other 2025
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2024.07.021
2025
The journal of obstetrics and gynaecology research ·doi:10.1111/jog.70075

ObjectiveIntestinal disorders (ID) impose a significant burden on preterm infants. Although previous studies have examined individual risk factors for types of ID such as necrotizing enterocolitis (NEC), meconium-related ileus (MRI), and fo…

2025
Scientific reports ·doi:10.1038/s41598-025-27867-0

Assisted hatching (AH) is a reproductive technique that artificially thins or breaches the zona pellucida to facilitate hatching. Despite its widespread use, there is insufficient evidence to conclude that AH improves pregnancy outcomes, pa…

article 2025
Reproductive medicine and biology ·doi:10.1002/rmb2.12654

PURPOSE: This study evaluated whether embryo cryopreservation before surgery (ECBS) improves clinical outcomes in in vitro fertilization (IVF) patients with endometrioma. METHODS: This retrospective study included patients aged 28-42 years…

2025
PloS one ·doi:10.1371/journal.pone.0329154

Research questionHow significant is the impact of dysmenorrhea on work productivity and quality of life (QoL) among Japanese women?.MethodsThis large-scale cross-sectional study was conducted using a web-based self-report questionnaire admi…

other 2025
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-024-01758-7

Adenomyomectomy, a therapeutic option for women with adenomyosis who wish to preserve their fertility, has been reported to pose a risk of developing placenta accreta spectrum (PAS) and uterine rupture in future pregnancies. However, the sp…

other 2025
Trials ·doi:10.1186/s13063-025-08750-9

BACKGROUND: Endometriosis presents as endometrial tissue growths outside the uterine cavity with its major symptoms including dysmenorrhea and infertility. Progestin preparations, such as dienogest, are the first-line therapy for endometrio…

article 2025
BMC women's health ·doi:10.1186/s12905-025-03817-w

Adenomyosis often causes dysmenorrhea in women of reproductive age. Progestins such as levonorgestrel intrauterine system (LNG-IUS) are often used for treatment, but some patients experience progesterone resistance, showing poor treatment r…

2025
Reproductive medicine and biology ·doi:10.1002/rmb2.12700

PurposeTo evaluate the applicability of overseas-approved dosage of relugolix combination tablets (relugolix 40 mg, estradiol [E2] 1 mg, and norethisterone acetate 0.5 mg) in healthy premenopausal Japanese women.MethodsA randomized, double-…

article 2025
F&S science ·doi:10.1016/j.xfss.2025.06.002

OBJECTIVE: To compare the transcriptomes induced by estrogens used in combined oral contraceptives (COCs): estetrol (E4), ethinylestradiol (EE), and estradiol (E2) in human primary endometriotic stromal cells. DESIGN: Endometriotic stromal…

preprint 2025
·doi:10.22541/au.174840847.70922257/v1

Objective: To elucidate the incidence, risk factors, and clinical characteristics of uterine torsion in pregnancies complicated by adenomyosis, which remains unstudied to date. Design: Retrospective cohort study. Setting: University Hospita…

case-report 2024
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/jog.16185

Uterine adenomyosis is a common disease in women of reproductive age that causes dysmenorrhea, abnormal uterine bleeding, infertility, and obstetric complications. Rarely, adenomyosis can lead to abscess formation, which is refractory to an…

article 2024
Reproductive health ·doi:10.1186/s12978-024-01739-8

BACKGROUND: Endometriosis-related pain encompassing dysmenorrhea, dyspareunia, and chronic pelvic pain, reduces the quality of life in premenopausal women. Although treatment options for endometriosis alleviate this pain, approximately one-…

rct 2024
Fertility and sterility ·doi:10.1016/j.fertnstert.2024.07.011

OBJECTIVE: To evaluate the efficacy and safety of 24-week cyclic administration of estetrol (E4) (15 mg)/drospirenone (DRSP) (3 mg) in Japanese patients with endometriosis. DESIGN: A 24-week, multicenter, randomized, double-blind, placebo-…

2024
Scientific reports ·doi:10.1038/s41598-024-69796-4

The cellular origin of clear cell ovarian carcinoma (CCOC), a major histological subtype of ovarian carcinoma remains elusive. Here, we explored the candidate cellular origin and identify molecular subtypes using integrated genomic/epigenom…